Cannabis company Organigram reports Q4 loss, revenue up 22 per cent from year ago

Advertisement

Advertise with us

MONCTON, N.B. - Cannabis company Organigram Holdings Inc. reported a smaller loss in its latest quarter compared with a year ago as its net revenue rose 22 per cent.

Read this article for free:


By clicking the button above, an account will be created and you will begin to receive some of our recommended newsletters. You may opt out of any newsletter by visiting your Email and Communication Preferences page or by clicking "unsubscribe" at the bottom of any email.

or

Already have an account? Log in here »

To continue reading, please subscribe:

Digital Subscription

One year of digital access for only $1.44 a week*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles

*Billed as $5.77 plus GST every four weeks. After 52 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.

To continue reading, please subscribe:

Add Free Press access to your Brandon Sun subscription for only an additional

$1 for the first 4 weeks*

  • Enjoy unlimited reading on winnipegfreepress.com
  • Read the E-Edition, our digital replica newspaper
  • Access News Break, our award-winning app
  • Play interactive puzzles
Start now

*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.

Hey there, time traveller!
This article was published 23/11/2021 (1789 days ago), so information in it may no longer be current.

MONCTON, N.B. – Cannabis company Organigram Holdings Inc. reported a smaller loss in its latest quarter compared with a year ago as its net revenue rose 22 per cent.

The company says it lost $26 million for the quarter ended Aug. 31 compared with a loss of $38.6 million in the same quarter last year.

The company says the smaller loss was due to higher gross margins, partially offset by impairment charges.

Growing cannabis plants intended for the medical marijuana market are shown at OrganiGram in Moncton, N.B., on April 14, 2016. THE CANADIAN PRESS/Ron Ward
Growing cannabis plants intended for the medical marijuana market are shown at OrganiGram in Moncton, N.B., on April 14, 2016. THE CANADIAN PRESS/Ron Ward

Net revenue for what was the company’s fourth quarter totalled $24.9 million, up from $20.4 million a year ago.

Organigram says it grew its share of the recreational cannabis market to seven per cent compared with 5.4 per cent in its third quarter.

Shares in the company were up 16 cents or nearly seven per cent at $2.53 in trading on the Toronto Stock Exchange.

This report by The Canadian Press was first published Nov. 23, 2021.

Companies in this story: (TSX:OGI)

Report Error Submit a Tip

Business

LOAD BUSINESS ARTICLES